-
Symbol
-
GLMD on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, NIS 1.80 par value per share
-
Latest Disclosed Ownership
-
44.1K shares
-
Security Ownership
-
2.6%
Allen Baharaff ownership in Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD)
2025-02-18 - Allen Baharaff has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 44.1K shares of Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD).
This represents 2.6% percent ownership of the company.